Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation

Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation

Resource Type

CF Research News

Authors

Gitte Berkers, Renske van der Meer, Peter van Mourik, Annelotte M Vonk, Evelien Kruisselbrink, Sylvia Wf Suen, Harry Gm Heijerman, Christof J Majoor, Gerard H Koppelman, Jolt Roukema, Hettie M Janssens, Yolanda B de Rijke, E Marleen Kemper
Jeffrey M Beekman, Cornelis K van der Ent, Hugo R de Jonge

References

J Cyst Fibros. 2020 Jun 1;S1569-1993(20)30127-2. doi: 10.1016/j.jcf.2020.04.014. Online ahead of print.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

CFTR [3]
Curcumin [4]
Genistein [5]
Ivacaftor [6]
Organoids [7]

Date

Monday, June 1, 2020

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [8]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/clinical-effects-three-cftr-potentiator-treatments-curcumin

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-19-00483R2_FINAL_Beekman_030920.pdf [2] https://pubmed.ncbi.nlm.nih.gov/32499204/ [3] https://www.ecfs.eu/research-article-keywords/cftr [4] https://www.ecfs.eu/research-article-keywords/curcumin [5] https://www.ecfs.eu/research-article-keywords/genistein [6] https://www.ecfs.eu/research-article-keywords/ivacaftor [7] https://www.ecfs.eu/research-article-keywords/organoids [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines